Biology Reference
In-Depth Information
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. (1999).
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-
like receptor 2,
J. Biol. Chem.
, 274, pp. 17406-17409.
Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol,
N., Gillen, M., Chu, K., Rasmussen, C., Rasmussen, H., Kufe, C., Weichselbaum,
R. and Hanna, N. (2004). TNFerade biologic, an adenovector with a radiation-
inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I
study in patients with solid tumors,
J. Clin. Oncol
., 22, pp. 592-601.
Seternes, T., Dalmo, R., Hoffman, J., Bøgwald, J., Zykova, S. and Smedsrød, B. (2001).
Scavenger-receptor-mediated endocytosis of lipopolysaccharide in Atlantic cod
(
Gadus morhua
L.),
J. Exp. Biol.
, 204, pp. 4055-4064.
Sharma, V. K. and Dellinger, R. P. (2003). Recent developments in the treatment of
sepsis.
Expert Opin. Investig. Drugs
,
12, pp. 139-152.
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto,
M. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on
Toll-like receptor 4,
J. Exp. Med
., 189, pp. 1777-1782.
Shiozaki, M., Doi, H., Tanaka, D., Shimozato, T. and Kurakata, S. (2006). Syntheses of
glucose analogues of E5564 as a highly potent anti-sepsis drug candidate,
Bioorg.
Med. Chem
., 14, pp. 3011-3016.
Shnyra, A., Lindberg, A. (1995). Scavenger receptor pathway for lipopolysaccharide
binding to Kupffer and endothelial liver cells in vitro,
Infect. Immun.
, 63, pp. 865-
873.
Sidhu, R. and Bollon, A. (1993). Tumor necrosis factor activities and cancer therapy - a
perspective,
Pharmacol. Ther
., 57, pp. 79-128.
Smith, C., Farrah, T. and Goodwin, R. (1994). The TNF receptor superfamily of cellular
and viral proteins: activation, costimulation, and death,
Cell
, 76, pp. 959-962.
Solomon, K., Kurt-Jones, E., Saladino, R., Stack, A., Dunn, I., Ferretti, M., Golenbock,
D., Fleisher, G. and Finberg, R. (1998).
Heterotrimeric G proteins physically
associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in
vitro responses to lipopolysaccharide,
J
.
Clin. Invest.
,
102,
pp.
2019-2027.
Spriggs, D. and Yates, S. (1992). Cancer chemotherapy, experiences with TNF-
administration in humans. In
Tumor Necrosis Factor: The Molecules and Their
Emerging Roles in Medicine
, ed. by Beutler, B., Raven Press: New York, pp. 383-
406.
Steel, D. and Whitehead, A. (1994). The major acute phase reactants: C-reactive protein,
serum amyloid P component and serum amyloid A protein,
Immunol. Today
, 15,
pp. 81-88.
Szlosarek, P., Charles, K. and Balkwill, F. (2006). Tumour necrosis factor-α as a tumour
promoter,
Eur. J Cancer
, 42, pp. 745-750.
Takeda, K. and Akira, S. (2004). TLR signaling pathways,
Sem. Immunol
., 16, pp. 3-9.
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and
Akira, S. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-
negative and Gram-positive bacterial cell wall components,
Immunity
, 11, pp. 443-
451.
